Attempts to reach a nationwide settlement over the opioid crisis with OxyContin maker Purdue Pharma have stalled.
opioids
Posted inOp-Eds, Opinion
Commentary: Usual responses to drug epidemics won’t reverse fentanyl fatalities
Solutions should focus on creative supply disruption, supervised opioid use sites and new forms of treatment.
advertisement
Posted inNation & World
Trump administration announces nearly $2 billion in opioid grants
The money is destined for states and local governments to help provide treatment and recovery services.
Posted inHealth, Local & State, News
High-dose opioid prescriptions fall sharply in Maine
Much of the decrease appears to have occurred since a law limiting such prescriptions began to take effect in 2017.
Posted inOp-Eds, Opinion
The Maine Millennial: Accounting for pain got lost amid addiction to profit
Drug companies and liquor bottlers can’t be expected to regulate themselves.
Posted inOp-Eds, Opinion
U.S. Attorney Frank: Law enforcement had key role in decline in Maine overdose deaths
Though recent coverage didn’t mention it, a surge in federal prosecutions has been a deterrent to users and dealers.
Posted inHealth, Nation & World
Boom in overdose-reversing drug is linked to fewer deaths
The United States is in the midst of the deadliest drug overdose epidemic in its history.
Posted inBusiness, Nation & World, News
Big question in opioid suits: How to divide any settlement
About 2,000 state and local governments seek to hold the drug industry accountable for the nation’s opioid crisis.
Posted inOp-Eds, Opinion
Sen. Jackson: It is time to hold opioid manufacturers accountable
Companies that distribute millions of doses of potentially deadly drugs in Maine should pay the cost of fixing the problems this has caused through higher license fees.
Posted inHealth, Life & Culture, Nation & World
Authorities shut down two Tennessee pharmacies’ opioid sales
Two people died and numerous others were hospitalized for overdoses shortly after obtaining drugs from the pharmacies.